Single dose of Glycoprotein K (gK)-deleted HSV-1 live-attenuated virus protects mice against lethal vaginal challenge with HSV-1 and HSV-2 and induces lasting T cell memory immune responses

The Amino Terminus of Herpes Simplex Virus 1 Glycoprotein K Is Required for Virion Entry via the Paired Immunoglobulin-Like Type-2 Receptor Alpha

(2013) S. Chowdhury et al.   JOURNAL OF VIROLOGY

HSV-1 strain McKrae is more neuroinvasive than HSV-1 KOS after corneal or vaginal inoculation in mice

(2013) Hong Wang et al.   VIRUS RESEARCH

Herpes simplex virus type 1 is the main cause of genital herpes in women of Natal, Brazil

(2012) Valeska S.S. Pereira et al.   European Journal of Obstetrics & Gynecology and Reproductive Biology

The challenge of developing a herpes simplex virus 2 vaccine

(2012) Lesia K Dropulic et al.   Expert Review of Vaccines

Live Attenuated Herpes Simplex Virus 2 Glycoprotein E Deletion Mutant as a Vaccine Candidate Defective in Neuronal Spread

(2012) Sita Awasthi et al.   JOURNAL OF VIROLOGY

A vaccine strategy that protects against genital herpes by establishing local memory T cells

(2012) Haina Shin et al.   NATURE

Virus-cell fusion as a trigger of innate immunity dependent on the adaptor STING

(2012) Christian K Holm et al.   NATURE IMMUNOLOGY

Efficacy Results of a Trial of a Herpes Simplex Vaccine

(2012) Robert B. Belshe et al.   NEW ENGLAND JOURNAL OF MEDICINE

Immune epitope database analysis resource

(2012) Y. Kim et al.   NUCLEIC ACIDS RESEARCH

Development of a Glycoprotein D-Expressing Dominant-Negative and Replication-Defective Herpes Simplex Virus 2 (HSV-2) Recombinant Viral Vaccine against HSV-2 Infection in Mice

(2011) N. V. Akhrameyeva et al.   JOURNAL OF VIROLOGY

A Live-Attenuated HSV-2 ICP0− Virus Elicits 10 to 100 Times Greater Protection against Genital Herpes than a Glycoprotein D Subunit Vaccine

(2011) William P. Halford et al.   PLoS One

Sensing herpes: more than toll

(2011) Jesper Melchjorsen   REVIEWS IN MEDICAL VIROLOGY

Immunization with a dominant-negative recombinant Herpes Simplex Virus (HSV) type 1 protects against HSV-2 genital disease in guinea pigs

(2010) Richard Brans et al.   BMC MICROBIOLOGY

The Herpes Simplex Virus Type 1 UL20 Protein and the Amino Terminus of Glycoprotein K (gK) Physically Interact with gB

(2010) V. N. Chouljenko et al.   JOURNAL OF VIROLOGY

The Herpes Simplex Virus Type 1 (HSV-1) Glycoprotein K(gK) is Essential for Viral Corneal Spread and Neuroinvasiveness

(2009) Andrew T. David et al.   CURRENT EYE RESEARCH

Prevention of Genital Herpes Simplex Virus Type 1 and 2 Disease in Mice Immunized with a gD-Expressing Dominant-Negative Recombinant HSV-1

(2009) Richard Brans et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

The Amino Terminus of Herpes Simplex Virus Type 1 Glycoprotein K (gK) Modulates gB-Mediated Virus-Induced Cell Fusion and Virion Egress

(2009) V. N. Chouljenko et al.   JOURNAL OF VIROLOGY

Innate and Adaptive Immune Responses to Herpes Simplex Virus

(2009) Tracy Chew et al.   Viruses-Basel

The potential impact of a prophylactic herpes simplex vaccine

(2008) Richard Rupp et al.   EXPERT OPINION ON EMERGING DRUGS

Functional and Physical Interactions of the Herpes Simplex Virus Type 1 UL20 Membrane Protein with Glycoprotein K

(2008) T. P. Foster et al.   JOURNAL OF VIROLOGY

A Replication-Competent, Neuronal Spread-Defective, Live Attenuated Herpes Simplex Virus Type 1 Vaccine

(2008) E. E. Brittle et al.   JOURNAL OF VIROLOGY

Asymptomatic Human CD4+ Cytotoxic T-Cell Epitopes Identified from Herpes Simplex Virus Glycoprotein B

(2008) A. A. Chentoufi et al.   JOURNAL OF VIROLOGY

Comparison of immunogenicity and protective efficacy of genital herpes vaccine candidates herpes simplex virus 2 dl5-29 and dl5-29-41L in mice and guinea pigs

(2008) Yo Hoshino et al.   VACCINE

Recombinant vesicular stomatitis virus-based west Nile vaccine elicits strong humoral and cellular immune responses and protects mice against lethal challenge with the virulent west Nile virus strain LSU-AR01

(2008) Arun V. Iyer et al.   VACCINE

Disruption of the UL41 gene in the herpes simplex virus 2 dl5-29 mutant increases its immunogenicity and protective capacity in a murine model of genital herpes

(2007) Timothy Dudek et al.   VIROLOGY